
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
[ Fri, May 08th 2020 ]: WOPRAI
Alethia Young Reiterated (ARWR) at Buy with Decreased Target to $58 on, May 8th, 2020


🞛 This publication is a summary or evaluation of another publication
Alethia Young of Cantor Fitzgerald, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy with Decreased Target from $60 to $58 on, May 8th, 2020.
Alethia has made no other calls on ARWR in the last 4 months.
There are 3 other peers that have a rating on ARWR. Out of the 3 peers that are also analyzing ARWR, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Upgraded from Sell to Hold on, Tuesday, March 24th, 2020
- Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, March 17th, 2020
This is the rating of the analyst that currently disagrees with Alethia
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $57 on, Friday, March 13th, 2020
Similar Stocks and Investing Publications
[ Wed, Apr 15th 2020 ]: WOPRAI
[ Tue, Mar 24th 2020 ]: WOPRAI
[ Tue, Mar 17th 2020 ]: WOPRAI
[ Fri, Mar 13th 2020 ]: WOPRAI
[ Thu, Feb 06th 2020 ]: WOPRAI
[ Mon, Feb 03rd 2020 ]: WOPRAI
[ Fri, Jan 31st 2020 ]: WOPRAI
[ Fri, Jan 31st 2020 ]: WOPRAI
[ Wed, Jan 22nd 2020 ]: WOPRAI
[ Tue, Jan 21st 2020 ]: WOPRAI
[ Tue, Jan 21st 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI